Evolent Health, Inc.
EVHHealthcareNASDAQHealth Information Services · Last scanned Jul 18, 2026
Scan Results
Daily timeframeEvolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The $653.5M market capitalization puts EVH squarely in small-cap range for its industry. The company offers integrated value-based care platform for health plan administration and management.
Market Cap
$653.5M
Beta
0.77
P/E (TTM)
—
P/E (Fwd)
15.09
EPS (TTM)
$-4.80
EPS (Fwd)
$0.38
ROE
-65.1%
ROA
-0.4%
Cash
$142.0M
Total Debt
$985.4M
Free CF
$52.9M
52W Change
-39.0%
Annual Financials
Cash vs Debt
Evolent Health, Inc. carries $985.4M in total debt against $142.0M in cash reserves — debt is roughly 6.9x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $52.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -65.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $1.35B (2022) to $1.88B (2025), reflecting a 39% increase over the period.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Evolent Health, Inc.'s trajectory.